178 related articles for article (PubMed ID: 31274605)
21. Multimodal
Karlberg A; Berntsen EM; Johansen H; Myrthue M; Skjulsvik AJ; Reinertsen I; Esmaeili M; Dai HY; Xiao Y; Rivaz H; Borghammer P; Solheim O; Eikenes L
World Neurosurg; 2017 Dec; 108():989.e1-989.e8. PubMed ID: 28844925
[TBL] [Abstract][Full Text] [Related]
22. Image Guided Planning for Prostate Carcinomas With Incorporation of Anti-3-[18F]FACBC (Fluciclovine) Positron Emission Tomography: Workflow and Initial Findings From a Randomized Trial.
Schreibmann E; Schuster DM; Rossi PJ; Shelton J; Cooper S; Jani AB
Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):206-13. PubMed ID: 27511856
[TBL] [Abstract][Full Text] [Related]
23. Best Practices for
Tade FI; Sajdak RA; Gabriel M; Wagner RH; Savir-Baruch B
J Nucl Med Technol; 2019 Dec; 47(4):282-287. PubMed ID: 31182661
[No Abstract] [Full Text] [Related]
24. The diagnostic accuracy of detecting malignant transformation of low-grade glioma using O-(2-[18F]fluoroethyl)-l-tyrosine positron emission tomography: a retrospective study.
Bashir A; Brennum J; Broholm H; Law I
J Neurosurg; 2018 Apr; 130(2):451-464. PubMed ID: 29624154
[TBL] [Abstract][Full Text] [Related]
25.
Abiodun-Ojo OA; Akintayo AA; Akin-Akintayo OO; Tade FI; Nieh PT; Master VA; Alemozaffar M; Osunkoya AO; Goodman MM; Fei B; Schuster DM
J Nucl Med; 2019 Nov; 60(11):1531-1536. PubMed ID: 30954940
[TBL] [Abstract][Full Text] [Related]
26.
Seierstad T; Hole KH; Tulipan AJ; Strømme H; Lilleby W; Revheim ME; Hernes E
PET Clin; 2021 Apr; 16(2):167-176. PubMed ID: 33648662
[TBL] [Abstract][Full Text] [Related]
27. Unsupervised consensus cluster analysis of [18F]-fluoroethyl-L-tyrosine positron emission tomography identified textural features for the diagnosis of pseudoprogression in high-grade glioma.
Kebir S; Khurshid Z; Gaertner FC; Essler M; Hattingen E; Fimmers R; Scheffler B; Herrlinger U; Bundschuh RA; Glas M
Oncotarget; 2017 Jan; 8(5):8294-8304. PubMed ID: 28030820
[TBL] [Abstract][Full Text] [Related]
28. Rate of incidental central nervous system meningioma detected in patients undergoing 18F-fluciclovine PET/CT imaging for evaluation of prostate cancer.
Baiomy A; Schellingerhout D; Chapin BF; Weinberg JS; Raza SM; Macapinlac H; Ravizzini G
Nucl Med Commun; 2021 Jul; 42(7):755-762. PubMed ID: 33741867
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of glioma.
Shaw TB; Jeffree RL; Thomas P; Goodman S; Debowski M; Lwin Z; Chua B
J Med Imaging Radiat Oncol; 2019 Oct; 63(5):650-656. PubMed ID: 31368665
[TBL] [Abstract][Full Text] [Related]
30. Fluorine-18-Labeled Fluciclovine PET/CT in Clinical Practice: Factors Affecting the Rate of Detection of Recurrent Prostate Cancer.
Savir-Baruch B; Lovrec P; Solanki AA; Adams WH; Yonover PM; Gupta G; Schuster DM
AJR Am J Roentgenol; 2019 Oct; 213(4):851-858. PubMed ID: 31216198
[No Abstract] [Full Text] [Related]
31. Comparison of effects of 18F-FDG PET-CT and MRI in identifying and grading gliomas.
Song PJ; Lu QY; Li MY; Li X; Shen F
J Biol Regul Homeost Agents; 2016; 30(3):833-838. PubMed ID: 27655507
[TBL] [Abstract][Full Text] [Related]
32. A PET/MRI study towards finding the optimal [
Elschot M; Selnæs KM; Sandsmark E; Krüger-Stokke B; Størkersen Ø; Tessem MB; Moestue SA; Bertilsson H; Bathen TF
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):695-703. PubMed ID: 27817158
[TBL] [Abstract][Full Text] [Related]
33. 18F-FACBC PET/MRI in Diagnostic Assessment and Neurosurgery of Gliomas.
Karlberg A; Berntsen EM; Johansen H; Skjulsvik AJ; Reinertsen I; Dai HY; Xiao Y; Rivaz H; Borghammer P; Solheim O; Eikenes L
Clin Nucl Med; 2019 Jul; 44(7):550-559. PubMed ID: 31107743
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic accuracy of
He Q; Zhang L; Zhang B; Shi X; Yi C; Zhang X
BMC Cancer; 2019 Apr; 19(1):332. PubMed ID: 30961564
[TBL] [Abstract][Full Text] [Related]
35. Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (
Bach-Gansmo T; Nanni C; Nieh PT; Zanoni L; Bogsrud TV; Sletten H; Korsan KA; Kieboom J; Tade FI; Odewole O; Chau A; Ward P; Goodman MM; Fanti S; Schuster DM; Willoch F
J Urol; 2017 Mar; 197(3 Pt 1):676-683. PubMed ID: 27746282
[TBL] [Abstract][Full Text] [Related]
36. Prospective evaluation of
Jambor I; Kuisma A; Kähkönen E; Kemppainen J; Merisaari H; Eskola O; Teuho J; Perez IM; Pesola M; Aronen HJ; Boström PJ; Taimen P; Minn H
Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):355-364. PubMed ID: 29147764
[TBL] [Abstract][Full Text] [Related]
37. Combined 68Ga-NOTA-PRGD2 and 18F-FDG PET/CT Can Discriminate Uncommon Meningioma Mimicking High-Grade Glioma.
Li D; Zhang J; Ji N; Zhao X; Zheng K; Qiao Z; Li F; Lang L; Iagaru A; Niu G; Zhu Z; Chen X
Clin Nucl Med; 2018 Sep; 43(9):648-654. PubMed ID: 30052597
[TBL] [Abstract][Full Text] [Related]
38. Distinguishing Progression from Pseudoprogression in Glioblastoma Using
Nabavizadeh A; Bagley SJ; Doot RK; Ware JB; Young AJ; Ghodasara S; Zhao C; Anderson H; Schubert E; Carpenter EL; Till J; Henderson F; Pantel AR; Chen HI; Lee JYK; Amankulor NM; O'Rourke DM; Desai A; Nasrallah MP; Brem S
J Nucl Med; 2023 Jun; 64(6):852-858. PubMed ID: 36549916
[TBL] [Abstract][Full Text] [Related]
39. Comparison of 18F-Fluciclovine PET/CT and 99mTc-MDP bone scan in detection of bone metastasis in prostate cancer.
Chen B; Wei P; Macapinlac HA; Lu Y
Nucl Med Commun; 2019 Sep; 40(9):940-946. PubMed ID: 31343613
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients.
Lapa C; Linsenmann T; Monoranu CM; Samnick S; Buck AK; Bluemel C; Czernin J; Kessler AF; Homola GA; Ernestus RI; Löhr M; Herrmann K
J Nucl Med; 2014 Oct; 55(10):1611-6. PubMed ID: 25125481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]